First Nonopioid Treatment To Ease Withdrawal Symptoms Approved By FDA

By May 17, 2018 News No Comments

Regulators say that Lucemyra is not an addiction medicine but that it can be part of a longer-term treatment plan. “The physical symptoms of opioid withdrawal can be one of the biggest barriers for patients seeking help and ultimately overcoming addiction,” says Dr. Scot Gottlieb, the FDA’s commissioner.